Literature DB >> 872095

Reduction in cellular tumorigenicity after mycoplasma infection and elimination of mycoplasma from infected cultures by passage in nude mice.

O P van Diggelen, S I Shin, D M Phillips.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 872095

Source DB:  PubMed          Journal:  Cancer Res        ISSN： 0008-5472            Impact factor:   12.701


× No keyword cloud information.
  10 in total

1.  Use of ciprofloxacin and BM-Cyclin in mycoplasma decontamination.

Authors:  C Somasundaram; W Nicklas; S Matzku
Journal:  In Vitro Cell Dev Biol       Date:  1992 Nov-Dec

2.  Identification and purification of arginine deiminase that originated from Mycoplasma arginini.

Authors:  K Sugimura; S Fukuda; Y Wada; M Taniai; M Suzuki; T Kimura; T Ohno; K Yamamoto; I Azuma
Journal:  Infect Immun       Date:  1990-08       Impact factor: 3.441

3.  The use of ciprofloxacin for the elimination of mycoplasma from naturally infected cell lines.

Authors:  J M Mowles
Journal:  Cytotechnology       Date:  1988-11       Impact factor: 2.058

4.  Elimination of mycoplasmas from cell cultures by a novel soft agar technique.

Authors:  H Kotani; G Butler; D Heggan; G J McGarrity
Journal:  In Vitro Cell Dev Biol       Date:  1991-06

5.  Elimination of Mycoplasma hyorhinis infections from four cell lines.

Authors:  T Gurney; M J Woolf; L J Abplanalp; N H McKittrick; J N Dietz; B C Cole
Journal:  In Vitro       Date:  1981-11

6.  Endogenous HPRT activity in mycoplasmas isolated from cell cultures.

Authors:  O P Van Diggelen; G J McGarrity; S I Shin
Journal:  In Vitro       Date:  1978-09

7.  Elimination of the M. hyorhinis from murine neuroblastoma cell lines by in vivo passage.

Authors:  J M Lombardo; K W Lanks
Journal:  In Vitro       Date:  1982-03

8.  Treatment of mycoplasma contamination in a large panel of cell cultures.

Authors:  H G Drexler; S M Gignac; Z B Hu; A Hopert; E Fleckenstein; M Voges; C C Uphoff
Journal:  In Vitro Cell Dev Biol Anim       Date:  1994-05       Impact factor: 2.416

9.  High-throughput detection and multiplex identification of cell contaminations.

Authors:  Markus Schmitt; Michael Pawlita
Journal:  Nucleic Acids Res       Date:  2009-07-09       Impact factor: 16.971

10.  Development of Mast Cell and Eosinophil Hyperplasia and HLH/MAS-Like Disease in NSG-SGM3 Mice Receiving Human CD34+ Hematopoietic Stem Cells or Patient-Derived Leukemia Xenografts.

Authors:  Laura J Janke; Denise M Imai; Heather Tillman; Rosalinda Doty; Mark J Hoenerhoff; Jiajie J Xu; Zachary T Freeman; Portia Allen; Natalie Wall Fowlkes; Ilaria Iacobucci; Kirsten Dickerson; Charles G Mullighan; Peter Vogel; Jerold E Rehg
Journal:  Vet Pathol       Date:  2020-11-19       Impact factor: 2.221
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.